SCRI Tennessee Oncology Nashville — Nashville, Tennessee

SCRI Tennessee Oncology Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI Tennessee Oncology Nashville has participated in 9 clinical trials.

Therapeutic areas: Multiple Myeloma, Melanoma, Melanoma Stage III.

Sponsors: Takeda, Nektar Therapeutics, Arcus Biosciences, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Tennessee Oncology Nashville?

SCRI Tennessee Oncology Nashville has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Tennessee Oncology Nashville conducted?

SCRI Tennessee Oncology Nashville has 9 clinical trials on record. Their work covers Multiple Myeloma, Melanoma, Melanoma Stage III.

Is SCRI Tennessee Oncology Nashville accredited by Crixeo Clinical Trials?

SCRI Tennessee Oncology Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Tennessee Oncology Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.